Publication and Prizes
By kind permission of the Editor in Chief of the British Journal of Anaesthesia (BJA) the top scoring abstracts submitted to DAS 2023 will be considered for publication in a future electronic edition of the BJA. The organisers of DAS 2023 are delighted to be able to offer this opportunity to those submitting abstracts but draw attention to the following
- The final decision on publication rests solely with the E-I-C of the BJA or their designated deputy
- All abstracts accepted for publication will have to agree to appropriate editing (as required) within the time frame specified by the journal
- The BJA supports the highest standards in research ethics. Authors may be requested to provide evidence of their ethical approvals/ patient consent etc before publication is accepted
- Authors will have to agree to the terms and conditions of publication as required by the journal
- Any abstract selected for publication in the British Journal of Anaesthesia (BJA) cannot be published elsewhere in the same format.
- Consent must have been sought for case reports.
- Caldicott Guardian approval must be obtained where patient identifiable data is involved.
- Evaluations must be discussed and agreed by the Scientific Officer of the local regional ethics service if formal ethical approval is deemed not to be required. Ethical considerations and arrangements should be discussed in the methods section of the abstract. Please see the relevant paragraphs on the BJA Instructions to Authors web page (Guide for authors – British Journal of Anaesthesia – ISSN 0007-0912 (elsevier.com) for further details.
Abstracts from outside the UK and Ireland are expected to meet the ethical standards of their host country and comply with the BJA standards stated above.
During the submission process an author can select to have their abstract considered for the Innovation Prize at DAS 2023. Whilst not an exhaustive guide, the following would qualify an abstract to be considered for the innovation prize:
- A novel method of data collection
- A novel technique of training and teaching
- A novel finding in the lab/clinical application (not previously published)
- A novel device or monitor or a novel use of an established device (not yet commercially available)
- A novel clinical service or team training method/approach
All applicants should consider protecting their intellectual property before submitting their abstract. The protection of intellectual property is the ultimate responsibility of each applicant, and DAS is not responsible for any intellectual property submitted for the DAS 2023 meeting. Examples of protection might be (not an exhaustive list)
- A patent
- A registered design
- A trademark
- A copyright
June 1st 2023
Abstract Submission Open
May 15th 2023
Abstract Submission Closes
September 7th 2023
October 3rd 2023
Notification to Authors
October 24th 2023
End of Early Registration
August 31st 2023